Interestingly, loss of ARID1A is closely associated with MSI and EBV, which can lead to immune infiltration, activate the immune system to kill tumor cells, and appear to be a favorable prognostic factor in gastric cancer. This evidence concerns the gene ARID1A and gastric cancer.